Logo
x

Search

Subscribe Now

Gene

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration

  • December 3, 2020
Elanco and WEDterinary Collaborate to Develop Novel Therapies for Pets

    Elanco and WEDterinary Collaborate to Develop Novel Therapies for Pets

    • March 19, 2025
    Endo & Mallinckrodt Pharmaceuticals to Form a Combine Entity with $6.7B Cash-and-Stock

      Endo & Mallinckrodt Pharmaceuticals to Form a Combine Entity with $6.7B Cash-and-Stock

      • March 18, 2025
      Genentech Reports the FDA

        Genentech Reports the FDA's sBLA Acceptance for Gazyva to Treat Lupus Nephritis

        • March 5, 2025
        BeiGene Reports the US FDA approval for Tevimbra + CT as a 1L Treatment of Advanced ESCC

          BeiGene Reports the US FDA approval for Tevimbra + CT as a 1L Treatment of Advanced ESCC

          • March 5, 2025
          The CHMP Recommends Conditional Approval of Regeneron’s Linvoseltamab to Treat R/R Multiple Myeloma (MM)

            The CHMP Recommends Conditional Approval of Regeneron’s Linvoseltamab to Treat R/R Multiple Myeloma (MM)

            • March 3, 2025
            Foresight Diagnostic & Allogene Therapeutics Extend Collaboration to Develop Minimal Residual Disease (MRD) Assay

              Foresight Diagnostic & Allogene Therapeutics Extend Collaboration to Develop Minimal Residual Disease (MRD) Assay

              • February 28, 2025
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.